+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Chronic Kidney Disease Market by Type (Diagnosis, Treatment), Indication (Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis), End-User - Forecast 2024-2030- Product Image
Global Chronic Kidney Disease Market by Type (Diagnosis, Treatment), Indication (Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis), End-User - Forecast 2024-2030- Product Image
Sale

Global Chronic Kidney Disease Market by Type (Diagnosis, Treatment), Indication (Chronic Interstitial Nephritis, Diabetic Nephropathy, Glomerulonephritis), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977705
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chronic Kidney Disease Market grew from USD 128.45 billion in 2023 to USD 136.56 billion in 2024. It is expected to continue growing at a CAGR of 6.50%, reaching USD 199.64 billion by 2030.

The kidneys are essential organs that filter out toxins, excess salts, and urea, a waste product from normal body functions. When the kidneys are damaged, they cannot perform these functions effectively, accumulating harmful substances in the body. CKD is often progressive, which means it can worsen over time and may eventually lead to kidney failure, requiring dialysis or kidney transplantation. The increasing prevalence of chronic kidney disease, especially among the aging population, is expanding the need for chronic kidney disease treatments. Improved awareness about kidney health and the development of advanced diagnostics for early detection of CKD contribute to higher diagnosis rates, driving the growth of the chronic kidney disease market. The high cost of chronic kidney disease treatments hampers the market growth. Rising healthcare services and better access to medical care in many regions of the world that allow more people to receive treatment for conditions that contribute to CKD are expected to create opportunities for market growth.

Regional Insights

In the Americas, there is a high prevalence of CKD, largely attributed to increasing rates of diabetes and hypertension, which are significant risk factors for the disease. The Americas shows significant investment in healthcare infrastructure and a strong presence of healthcare services that boost the management of chronic diseases, including CKD. Awareness programs, advanced healthcare facilities, and government-funded initiatives also help manage and treat CKD. In South America, rising efforts to improve healthcare accessibility and quality with the increasing need for the management of chronic diseases are creating a platform for market growth of chronic kidney disease treatment in the Americas. The Asia-Pacific region presents a diverse picture due to varying socioeconomic status across countries. Countries such as China, India, Japan, and Australia have well-established healthcare systems capable of managing chronic diseases effectively. The awareness about CKD is growing in this region, and governments along with private organizations, are making strides towards better screening, awareness campaigns, and improving healthcare infrastructure. Europe has a robust healthcare infrastructure and relatively high awareness about CKD, aided by strong government support and healthcare policies that ensure relatively better management of the condition. The Middle East shows variability with affluent nations including, Saudi Arabia and the UAE investing heavily in healthcare, whereas less affluent areas struggle with similar issues as seen in developing regions. Africa faces more pronounced challenges in dealing with CKD due to limited healthcare infrastructure, lower awareness, and other socio-economic challenges that complicate disease management and treatment availability.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Chronic Kidney Disease Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing global prevalence of chronic kidney disease with the aging population
  • Supportive government and regulatory policies aimed at improving healthcare infrastructure
  • Growing public and medical community awareness regarding early screening and diagnosis of kidney ailments

Market Restraints

  • High cost and gap in product standardization across regions

Market Opportunities

  • Advancements in treatment and diagnostic technologies and product innovation
  • Expansion of telemedicine and remote monitoring technologies

Market Challenges

  • Limited commercialization of advanced kidney disease treatments

Market Segmentation Analysis

  • Type: Growing need for chronic kidney disease diagnosis solutions to determine the function of the kidneys
  • End-User: Growing accessibility of chronic kidney disease treatments through hospitals & clinics as they offer a broad range of services

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Chronic Kidney Disease Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Chronic Kidney Disease Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Approves Akebia Therapeutics' Vafseo for Treatment of Anemia in CKD Patients

Akebia Therapeutics, Inc. announced that Vafseo (vadadustat), their new oral medication, has received FDA approval to treat anemia in adults with chronic kidney disease (CKD) who have been on dialysis for a minimum of three months. This once-daily tablet functions as a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, which mimics the body's natural response to low oxygen levels, thereby enhancing the production of erythropoietin. This mechanism assists in managing anemia effectively. Vafseo has also gained approval in 37 other countries, marking a significant advancement in CKD treatment options.

FDA Approves Jardiance® for Chronic Kidney Disease, Specifies Non-Recommended Uses

The U.S. Food and Drug Administration (FDA) has recently granted approval for the use of Jardiance (empagliflozin) 10 mg tablets to help mitigate the risk of severe outcomes associated with chronic kidney disease (CKD) in adults at risk of progression. These outcomes include a sustained decline in the estimated glomerular filtration rate (eGFR), end-stage kidney disease, cardiovascular death, and hospitalization.

Signify Health Launches In-Home Kidney Health Evaluations for Medicare Advantage Members

Signify Health expanded its Diagnostic and Preventive Services by introducing an in-home kidney health evaluation for Medicare Advantage members. This assessment, conducted during an in-home health evaluation at no extra cost, aims to detect and manage kidney-related health issues early. It includes critical tests such as urinalysis (uACR) and estimating the glomerular filtration rate (eGFR). These results enable healthcare professionals and patients to collaboratively design personalized management plans, potentially comprising further tests, lifestyle adjustments, pharmaceutical interventions, and nephrologist referrals.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Chronic Kidney Disease Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Chronic Kidney Disease Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Apotex Inc., Asahi Kasei Corporation, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Centessa Pharmaceuticals Limited, DaVita Inc., Dialife SA, Dr. Reddys Laboratories Ltd., Evoqua Water Technologies LLC, Fresenius Medical Care AG, Galapagos NV, Hemoclean Co. Ltd., JMS Co., Ltd., Johnson & Johnson Services, Inc., Medtronic PLC, Merck & Co., Inc., Nikkiso Co., Ltd., Nipro Corporation, Novartis AG, NxStage Medical Inc., Otsuka Pharmaceutical Co., Ltd., Reata Pharmaceuticals Inc., Rockwell Medical Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Toray Medical Co., Ltd., Trivitron Healthcare, and XORTX Therapeutics Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Kidney Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type- Diagnosis

  • Blood Tests
  • Imaging Tests
  • Kidney Biopsy
  • Urine Tests

Treatment

  • Dialysis
  • Kidney Transplant

Medication

  • ACE Inhibitors
  • Angiotensin Receptor Blockers
  • Beta Blockers
  • Diuretics
  • Erythropoietin Stimulants
  • Finerenone
  • Glucagon-like Peptide-1 Receptor Agonists
  • Insulin
  • Metformin
  • Potassium Binders
  • Sodium-glucose Cotransporter-2 Inhibitors
  • Statins

Indication

  • Chronic Interstitial Nephritis
  • Diabetic Nephropathy
  • Glomerulonephritis
  • Hypertensive Nephropathy
  • Obstructive Nephropathy
  • Polycystic Kidney Disease

End-User

  • Ambulatory Surgery Centers
  • Diagnostic Centers & Laboratories
  • Hospitals & Clinics
  • Speciality Treatment Centers

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence of chronic kidney disease with the aging population
5.1.1.2. Supportive government and regulatory policies aimed at improving healthcare infrastructure
5.1.1.3. Growing public and medical community awareness regarding early screening and diagnosis of kidney ailments
5.1.2. Restraints
5.1.2.1. High cost and gap in product standardization across regions
5.1.3. Opportunities
5.1.3.1. Advancements in treatment and diagnostic technologies and product innovation
5.1.3.2. Expansion of telemedicine and remote monitoring technologies
5.1.4. Challenges
5.1.4.1. Limited commercialization of advanced kidney disease treatments
5.2. Market Segmentation Analysis
5.2.1. Type: Growing need for chronic kidney disease diagnosis solutions to determine the function of the kidneys
5.2.2. End-User: Growing accessibility of chronic kidney disease treatments through hospitals & clinics as they offer a broad range of services
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Chronic Kidney Disease Market, by Type
6.1. Introduction
6.2. Diagnosis
6.3. Treatment
7. Chronic Kidney Disease Market, by Indication
7.1. Introduction
7.2. Chronic Interstitial Nephritis
7.3. Diabetic Nephropathy
7.4. Glomerulonephritis
7.5. Hypertensive Nephropathy
7.6. Obstructive Nephropathy
7.7. Polycystic Kidney Disease
8. Chronic Kidney Disease Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Diagnostic Centers & Laboratories
8.4. Hospitals & Clinics
8.5. Speciality Treatment Centers
9. Americas Chronic Kidney Disease Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Chronic Kidney Disease Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Chronic Kidney Disease Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Approves Akebia Therapeutics' Vafseo for Treatment of Anemia in CKD Patients
12.3.2. FDA Approves Jardiance® for Chronic Kidney Disease, Specifies Non-Recommended Uses
12.3.3. Signify Health Launches In-Home Kidney Health Evaluations for Medicare Advantage Members
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CHRONIC KIDNEY DISEASE MARKET RESEARCH PROCESS
FIGURE 2. CHRONIC KIDNEY DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CHRONIC KIDNEY DISEASE MARKET DYNAMICS
FIGURE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CHRONIC KIDNEY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CHRONIC KIDNEY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CHRONIC KIDNEY DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY URINE TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY KIDNEY TRANSPLANT, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY KIDNEY TRANSPLANT, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANGIOTENSIN RECEPTOR BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANGIOTENSIN RECEPTOR BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIURETICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIURETICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FINERENONE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FINERENONE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY METFORMIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY METFORMIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY POTASSIUM BINDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY POTASSIUM BINDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CHRONIC INTERSTITIAL NEPHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CHRONIC INTERSTITIAL NEPHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GLOMERULONEPHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY GLOMERULONEPHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HYPERTENSIVE NEPHROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HYPERTENSIVE NEPHROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY OBSTRUCTIVE NEPHROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY OBSTRUCTIVE NEPHROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS & LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SPECIALITY TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SPECIALITY TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 122. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 123. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 124. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 125. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 126. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 127. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 134. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 135. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 136. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 137. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 138. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 139. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 156. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 186. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 187. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 188. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 189. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 190. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 191. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. CHINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 198. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 199. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 200. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 201. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 202. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 203. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. INDIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 210. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 222. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 223. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 224. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 225. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 226. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 227. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. JAPAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 234. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 235. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 236. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 237. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 238. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 246. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 247. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 248. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 249. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 250. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 251. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 255. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 258. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 259. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 260. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 261. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 262. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 263. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. SINGAPORE CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 270. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 271. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 272. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 273. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 274. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 275. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. SOUTH KOREA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 282. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 283. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 284. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 285. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 286. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 287. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. TAIWAN CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 294. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 295. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 296. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 297. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 298. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 299. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 300. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 301. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. THAILAND CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 306. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 307. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 308. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 309. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 310. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 311. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. VIETNAM CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 329. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 330. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 331. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 332. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 333. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 334. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 335. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
TABLE 336. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
TABLE 337. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 338. DENMARK CHRONIC KIDNEY DISEASE MARKET SIZE, BY INDICATION, 2024-2030 (US

Companies Mentioned

  • AbbVie Inc.
  • Allmed Medical Products Co., Ltd.
  • AngioDynamics, Inc.
  • Apotex Inc.
  • Asahi Kasei Corporation
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Centessa Pharmaceuticals Limited
  • DaVita Inc.
  • Dialife SA
  • Dr. Reddys Laboratories Ltd.
  • Evoqua Water Technologies LLC
  • Fresenius Medical Care AG
  • Galapagos NV
  • Hemoclean Co. Ltd.
  • JMS Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck & Co., Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Novartis AG
  • NxStage Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Reata Pharmaceuticals Inc.
  • Rockwell Medical Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Medical Co., Ltd.
  • Trivitron Healthcare
  • XORTX Therapeutics Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 136.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 199.64 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Image

Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • 118 Pages
  • Global
From
Global Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report by Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Clinical Nutrition For Chronic Kidney Diseases Market Size, Share & Trends Analysis Report by Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Image

Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • 120 Pages
  • Asia Pacific
From
Late-stage chronic kidney disease (CKD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Image

Late-stage chronic kidney disease (CKD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • 200 Pages
  • Global
From
Moderate and Severe Chronic Kidney Disease (CKD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Image

Moderate and Severe Chronic Kidney Disease (CKD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.